跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

安全信息

Y0001409

系统适用性试验用丙酸睾酮

European Pharmacopoeia (EP) Reference Standard

别名:

丙酸睾酮, 17β-Hydroxy-4-androsten-3-one 17-propionate, 17β-Propionyloxy-4-androsten-3-one, 4-Androsten-17β-ol-3-one 17-propionate

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C22H32O3
CAS号:
57-85-2
分子量:
344.49
Beilstein:
3221760
MDL编号:
MFCD00003653
UNSPSC代码:
41116107
PubChem化学物质编号:
329831409
NACRES:
NA.24

等级

pharmaceutical primary standard

API类

testosterone

制造商/商品名称

EDQM

药品控制

regulated under CDSA - not available from Sigma-Aldrich Canada

应用

pharmaceutical (small molecule)

包装形式

neat

储存温度

2-8°C

SMILES字符串

[H][C@@]12CCC3=CC(=O)CC[C@]3(C)[C@@]1([H])CC[C@]4(C)[C@H](CC[C@@]24[H])OC(=O)CC

InChI

1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1

InChI key

PDMMFKSKQVNJMI-BLQWBTBKSA-N

基因信息

human ... AR(367)

正在寻找类似产品? 访问 产品对比指南

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Testosterone propionate for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

相关产品

产品编号
说明
价格

T0100000

睾酮, European Pharmacopoeia (EP) Reference Standard

T0240000

癸酸睾酮, European Pharmacopoeia (EP) Reference Standard

T0250000

庚酸睾酮, European Pharmacopoeia (EP) Reference Standard

T0300000

丙酸睾酮, European Pharmacopoeia (EP) Reference Standard

T0210000

己酸睾酮, European Pharmacopoeia (EP) Reference Standard

T0260000

异己酸睾酮, European Pharmacopoeia (EP) Reference Standard

Y0000696

系统适用性试验用癸酸睾酮, European Pharmacopoeia (EP) Reference Standard

Y0000716

系统适用性试验用异己酸睾酮, European Pharmacopoeia (EP) Reference Standard

Y0001312

峰鉴别用庚酸睾酮, European Pharmacopoeia (EP) Reference Standard

Y0001317

系统适用性试验用庚酸睾酮, European Pharmacopoeia (EP) Reference Standard

Y0001313

庚酸睾酮杂质H, European Pharmacopoeia (EP) Reference Standard

1649007

丙酸睾酮, United States Pharmacopeia (USP) Reference Standard

1647001

环戊丙酸睾酮, United States Pharmacopeia (USP) Reference Standard

1648004

庚酸睾酮, United States Pharmacopeia (USP) Reference Standard

1646031

Testosterone Related Compound C, United States Pharmacopeia (USP) Reference Standard

1646097

Testosterone Related Compound I, United States Pharmacopeia (USP) Reference Standard

BP702

丙酸睾酮, British Pharmacopoeia (BP) Reference Standard

1646010

睾酮相关化合物A CIII, United States Pharmacopeia (USP) Reference Standard

BP319

癸酸睾酮, British Pharmacopoeia (BP) Reference Standard

BP321

异己酸睾酮, British Pharmacopoeia (BP) Reference Standard

BP1076

睾酮, British Pharmacopoeia (BP) Reference Standard

1647012

Testosterone Cypionate Related Compound A, United States Pharmacopeia (USP) Reference Standard

PHR2026

丙酸睾酮, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2027

睾酮, Pharmaceutical Secondary Standard; Certified Reference Material

1647023

Testosterone Cypionate Related Compound B, United States Pharmacopeia (USP) Reference Standard

Y0002163

睾酮, CRS, European Pharmacopoeia (EP) Reference Standard

Y0002174

睾酮, CRS, European Pharmacopoeia (EP) Reference Standard

Y0002145

Testosterone impurity I, CRS, European Pharmacopoeia (EP) Reference Standard

PHR9196

5α-雄甾烷-17β-醇-3-酮, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

警示用语：

Danger

危险分类

Acute Tox. 4 Oral - Aquatic Acute 1 - Carc. 2 - Repr. 1A

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

法规信息

监管及禁止进口产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Kyung Pyo Kang et al.
Molecular medicine reports, 9(6), 2061-2068 (2014-04-01)
Inflammation is a key mediator of renal ischemia-reperfusion (IR) injury. Gender disparities have been reported in acute and chronic kidney disease. In particular, males are considered to be more susceptible to renal ischemic injury compared with females according to animal
A B Firdous et al.
Food & function, 5(10), 2632-2645 (2014-08-29)
Prostate cancer incidence and mortality rates have increased over the past years. The purpose of the present study was to examine the molecular mechanism underlying the chemopreventive effects of quercetin on prostate cancer in an in vivo model. Sprague-Dawley male
Lei Wan et al.
Cancer prevention research (Philadelphia, Pa.), 7(12), 1228-1239 (2014-10-16)
Consumption of tomato products containing the carotenoid lycopene is associated with a reduced risk of prostate cancer. To identify gene expression patterns associated with early testosterone-driven prostate carcinogenesis, which are impacted by dietary tomato and lycopene, wild-type (WT) and transgenic
Negar M Ghahramani et al.
Biology of sex differences, 5, 8-8 (2014-07-01)
The biological basis for sex differences in brain function and disease susceptibility is poorly understood. Examining the role of gonadal hormones in brain sexual differentiation may provide important information about sex differences in neural health and development. Permanent masculinization of
Maarten C Bosland
Endocrinology, 155(12), 4629-4633 (2014-09-24)
Testosterone is increasingly prescribed to middle aged and older men, but the safety of this treatment has been called into question, and the possible risk of prostate cancer is unknown. We treated Wistar Cpb: WU rats chronically via slow-release Silastic
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门